BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol 2006; 12(42): 6756-6765 [PMID: 17106922 DOI: 10.3748/wjg.v12.i42.6756]
URL: https://www.wjgnet.com/1007-9327/full/v12/i42/6756.htm
(0) (0) (4989) (115)
Number Citing Articles
1
P. Roingeard, C. Hourioux. Hepatitis C virus core protein, lipid droplets and steatosis. Journal of Viral Hepatitis 2008; 15(3) doi: 10.1111/j.1365-2893.2007.00953.x
2
Hesham El Makhzangy, Gamal Esmat, Mohamed Said, Maissa ElRaziky, Soheir Shouman, Rasha Refai, Claire Rekacewicz, Rita Raafat Gad, Nicolas Vignier, Mohamed Abdel‐Hamid, Khaled Zalata, Pierre Bedossa, Stanislas Pol, Arnaud Fontanet, Mostafa K. Mohamed. Response to pegylated interferon alfa‐2a and ribavirin in chronic hepatitis C genotype 4. Journal of Medical Virology 2009; 81(9) doi: 10.1002/jmv.21570
3
Xiaoxia Wang, Yu Cao, Jia Guo, Dezhao Li, Haitao Zhang, Qingkun Song, Jun Lu. Association between MTTP genotype (-493G/T) polymorphism and hepatic steatosis in hepatitis C: a systematic review and meta-analysis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01916-x
4
Jens Bukh. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. Journal of Hepatology 2016; 65(1) doi: 10.1016/j.jhep.2016.07.035
5
George Papatheodoridis, Vasileios Lekakis, Rafael Esteban, Maria Buti. Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis. Clinics in Liver Disease 2026; 30(2) doi: 10.1016/j.cld.2026.01.013
6
José Tadeu Stefano, Claudia Pinto Marques Souza de Oliveira, Maria Lúcia Corrêa-Giannella, Vicência Mara Rodrigues de Lima, Sandra Valéria de Sá, Ellen Pierre de Oliveira, Evandro Sobroza de Mello, Daniel Giannella-Neto, Venâncio Avancini Ferreira Alves, Flair José Carrilho. Nonalcoholic Steatohepatitis (NASH) in OB/OB Mice Treated with Yo Jyo Hen Shi Ko (YHK): Effects on Peroxisome Proliferator-Activated Receptors (PPARs) and Microsomal Triglyceride Transfer Protein (MTP). Digestive Diseases and Sciences 2007; 52(12) doi: 10.1007/s10620-007-9810-8
7
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016;  doi: 10.1007/978-3-319-26587-2_10-1
8
Christophe Hézode, Elie Serge Zafrani, Françoise Roudot–Thoraval, Charlotte Costentin, Ali Hessami, Magali Bouvier–Alias, Fatiha Medkour, Jean–Michel Pawlostky, Sophie Lotersztajn, Ariane Mallat. Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C. Gastroenterology 2008; 134(2) doi: 10.1053/j.gastro.2007.11.039
9
Francesco Negro. Steatosis in chronic hepatitis C: friend or foe?. Liver International 2008; 28(3) doi: 10.1111/j.1478-3231.2008.01679.x
10
Stephen A. Harrison, Djamal Abdurakhmanov, Mitchell L. Shiffman, Igor Bakulin, Wlodzimierz Mazur, Maribel Rodriguez-Torres, Giovanni Faria Silva, Hugo Cheinquer, Diethelm Messinger, Edward V. Connell, Michael McKenna, Fernando Tatsch, K. Rajender Reddy. Intensified Peginterferon α-2a Dosing Increases Sustained Virologic Response Rates in Heavy, High Viral Load Hepatitis C Genotype 1 Patients With High Low-density Lipoprotein. Journal of Clinical Gastroenterology 2013; 47(3) doi: 10.1097/MCG.0b013e31826102eb
11
Ludovico Abenavoli, Samir Rouabhia. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?. Expert Review of Gastroenterology & Hepatology 2013; 7(4) doi: 10.1586/egh.13.13
12
Aleksandra Berkan‐Kawińska, Anna Piekarska, Ewa Janczewska, Beata Lorenc, Magdalena Tudrujek‐Zdunek, Krzysztof Tomasiewicz, Hanna Berak, Andrzej Horban, Dorota Zarębska‐Michaluk, Paweł Pabjan, Iwona Buczyńska, Monika Pazgan‐Simon, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Jakub Klapaczyński, Włodzimierz Mazur, Agnieszka Czauż‐Andrzejuk, Łukasz Socha, Łukasz Laurans, Aleksander Garlicki, Marek Sitko, Jerzy Jaroszewicz, Jolanta Citko, Beata Dobracka, Rafał Krygier, Jolanta Białkowska‐Warzecha, Olga Tronina, Teresa Belica‐Wdowik, Barbara Baka‐Ćwierz, Robert Flisiak. Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study. Liver International 2021; 41(8) doi: 10.1111/liv.14858
13
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA Journal 2014; 5(1) doi: 10.1186/1878-5085-5-21
14
Catalina Mihai, Bogdan Mihai, Anca Trifan, Carol Stanciu, Liana Gheorghe, Mircea Diculescu, Manuela Curescu, Ciprian Brisc, Adrian Goldis, Simona Bataga, Larisa Sandulescu, Ion Rogoveanu, Andrada Seicean, Cristina Cijevschi Prelipcean. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral Therapy. Hepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.58022
15
N. Capitanio, D. Moradpour, C. Piccoli. Hepatitis C virus proteins promote mitochondrial bioenergetic dysfunction and nitro-oxidative stress: insights into pathogenesis. Drug Discovery Today: Disease Mechanisms 2009; 6(1-4) doi: 10.1016/j.ddmec.2008.12.001
16
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infection. Orvosi Hetilap 2011; 152(38) doi: 10.1556/OH.2011.29209
17
Silvia Mirandola, Christoph H. Österreicher, Moira Marcolongo, Christian Datz, Elmar Aigner, Anne Schlabrakowski, Stefano Realdon, Martina Gerotto, Alfredo Alberti, Felix Stickel. Microsomal triglyceride transfer protein polymorphism (−493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver International 2009; 29(4) doi: 10.1111/j.1478-3231.2008.01892.x
18
David van der Poorten, Mahsa Shahidi, Enoch Tay, Jayshree Sesha, Kayla Tran, Duncan McLeod, Jane S. Milliken, Vikki Ho, Lionel W. Hebbard, Mark W. Douglas, Jacob George, Jean-Pierre Vartanian. Hepatitis C Virus Induces the Cannabinoid Receptor 1. PLoS ONE 2010; 5(9) doi: 10.1371/journal.pone.0012841
19
V.J. Desmet, Juan Rosai. Rosai and Ackerman's Surgical Pathology. 2011;  doi: 10.1016/B978-0-323-06969-4.00001-5
20
Francesco Negro, Lawrence Serfaty. Peroxisome Proliferator‐Activated Receptors and Hepatitis C Virus‐Induced Insulin Resistance. PPAR Research 2009; 2009(1) doi: 10.1155/2009/483485
21
Consuelo Fernández-Miranda, María Luisa Manzano, Inmaculada Fernández, Guadalupe López-Alonso, Pilar Gómez, Rosa Ayala, David Lora, Gregorio Castellano. Asociación entre hiperhomocisteinemia y esteatosis hepática en pacientes con hepatitis crónica C. Medicina Clínica 2011; 136(2) doi: 10.1016/j.medcli.2010.05.024
22
Wendi Qin, Xuxiang Zhang, Liuyan Yang, Lizhi Xu, Zongyao Zhang, Jun Wu, Yaping Wang. Microcystin-LR altered mRNA and protein expression of endoplasmic reticulum stress signaling molecules related to hepatic lipid metabolism abnormalities in mice. Environmental Toxicology and Pharmacology 2015; 40(1) doi: 10.1016/j.etap.2015.05.002
23
Rita Raafat Gad, Sylvia Males, Hesham El Makhzangy, Soheir Shouman, Aboubakr Hasan, Mohamed Attala, Mostafa El Hoseiny, Khaled Zalata, Mohamed Abdel‐Hamid, Arnaud Fontanet, Mostafa K. Mohamed, Gamal Esmat. Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C. Liver International 2008; 28(8) doi: 10.1111/j.1478-3231.2008.01750.x
24
Huiying Rao, Lai Wei, Hong Li, Ruifeng Yang, Haiying Zhang, Jia Shang, Hong Chen, Jun Li, Qing Xie, Zhiliang Gao, Lei Wang, Jia Wei, Jianning Jiang, Yongtao Sun. Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a Chinese Han population. Journal of Gastroenterology and Hepatology 2015; 30(6) doi: 10.1111/jgh.12901
25
Marcia Wang Matsuoka, Ilka Regina Souza de Oliveira, Azzo Widman, Arnaldo Zanoto, Sérgio Keidi Kodaira, Leonardo Ellery Marinho, Wilson Jacob Filho, Giovanni Guido Cerri. Contribuição da ultrassonografia para o diagnóstico das alterações histopatológicas presentes na hepatite C crônica, com ênfase na esteatose hepática: Parte I. Radiologia Brasileira 2011; 44(3) doi: 10.1590/S0100-39842011000300004
26
Abeer Awad, Mohamed El-Kassas. Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
27
Hsieh Ming‐Ju, Hsieh Yih‐Shou, Chen Tzy‐Yen, Chiou Hui‐Ling. Hepatitis C virus E2 protein induce reactive oxygen species (ROS)‐related fibrogenesis in the HSC‐T6 hepatic stellate cell line. Journal of Cellular Biochemistry 2011; 112(1) doi: 10.1002/jcb.22926
28
Chunhua Li, Ling Lu, Donald G. Murphy, Francesco Negro, Hiroaki Okamoto. Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e.  Journal of General Virology 2014; 95(8) doi: 10.1099/vir.0.065128-0
29
José Núñez Troconis. Chlamydia trachomatis. Co-factor or factor in cancer of the cervix?. Investigación Clínica 2021; 62(3) doi: 10.22209/IC.v62n3a06
30
Patrice André, Vincent Lotteau. Hepatitis C virus assembly: When fat makes it easier. Journal of Hepatology 2008; 49(1) doi: 10.1016/j.jhep.2008.04.005
31
Naoko Kubota, Yasutaka Inayoshi, Naoko Satoh, Takashi Fukuda, Kenta Iwai, Hiroshi Tomoda, Michinori Kohara, Kazuhiro Kataoka, Akira Shimamoto, Yasuhiro Furuichi, Akio Nomoto, Akira Naganuma, Shusuke Kuge. HSC90 is required for nascent hepatitis C virus core protein stability in yeast cells. FEBS Letters 2012; 586(16) doi: 10.1016/j.febslet.2012.05.023
32
Naoko KUBOTA, Akira NAGANUMA, Shusuke KUGE. DNA MICROARRAY ANALYSIS OF TRANSCRIPTIONAL RESPONSES OF YEAST CELLS TO EXPRESSION OF CORE PROTEIN OF HEPATITIS C VIRUS. The Journal of Toxicological Sciences 2007; 32(2) doi: 10.2131/jts.32.201
33
Ludovico Abenavoli, Piero L Almasio. Chronic hepatitis C infection and insulin resistance: two best friends. Expert Review of Anti-infective Therapy 2011; 9(8) doi: 10.1586/eri.11.72
34
Abdallah M. AlQaraawi, Faisal M. Sanai, Hussa Al-Husseini, Ali Albenmousa, Abdulmalik AlSheikh, Lubna Rizwan Ahmed, Ahmad Hersi, Molfi M. Al-Otaibi, Mohammed Syed, Safiyya M. Ali, Waleed Al-hamoudi, Khalid A. Alswat, Ayman A. Abdo. Prevalence and Impact of Hepatic Steatosis on the Response to Antiviral Therapy in Saudi Patients with Genotypes 1 and 4 Chronic Hepatitis C. Digestive Diseases and Sciences 2011; 56(4) doi: 10.1007/s10620-010-1417-9
35
Joel Henrique Ellwanger, Valéria de Lima Kaminski, Jacqueline María Valverde-Villegas, Daniel Simon, Vagner Ricardo Lunge, José Artur Bogo Chies. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming. Infection, Genetics and Evolution 2018; 66 doi: 10.1016/j.meegid.2017.08.011
36
Michael C. Kew. The Role of Cirrhosis in the Etiology of Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2014; 45(1) doi: 10.1007/s12029-013-9556-9
37
P. O. Bogomolov, A. O. Bueverov, E. A. Fedosina, V. E. Bakirova, S. V. Koblov. Clinical parallels and experience of antivira l therapy in chronic hepatitis with polycystic ovary syndrome. Experimental and Clinical Gastroenterology 2020; 174(2) doi: 10.31146/1682-8658-ecg-174-2-71-79
38
Hans Peter Dienes, Uta Drebber. Pathologie. Pathologie 2020;  doi: 10.1007/978-3-642-04557-8_7
39
Kazuya OGAWA, Takayuki HISHIKI, Yuko SHIMIZU, Kenji FUNAMI, Kazuo SUGIYAMA, Yusuke MIYANARI, Kunitada SHIMOTOHNO. Hepatitis C virus utilizes lipid droplet for production of infectious virus. Proceedings of the Japan Academy, Series B 2009; 85(7) doi: 10.2183/pjab.85.217
40
Amedeo Lonardo, Paola Loria, Nicola Carulli. Dysmetabolic changes associated with HCV: a distinct syndrome?. Internal and Emergency Medicine 2008; 3(2) doi: 10.1007/s11739-008-0127-1
41
V. Pène, C. Hernandez, C. Vauloup‐Fellous, J. Garaud‐Aunis, A. R. Rosenberg. Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. Journal of Viral Hepatitis 2009; 16(10) doi: 10.1111/j.1365-2893.2009.01118.x
42
Andrzej Gabriel, Michał Kukla, Brygida Adamek, Kamil Tabor, Grzegorz Banasik, Maciej Horyniecki, Waldemar Halota. Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients. Polish Journal of Pathology 2019; 69(4) doi: 10.5114/pjp.2018.78517
43
Kohichiroh Yasui, Takahisa Kawaguchi, Toshihide Shima, Hironori Mitsuyoshi, Kojiro Seki, Rei Sendo, Masayuki Mizuno, Yoshito Itoh, Fumihiko Matsuda, Takeshi Okanoue. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. Journal of Gastroenterology 2015; 50(8) doi: 10.1007/s00535-014-1018-z
44
Giovanni Quarato, Rosella Scrima, Francesca Agriesti, Darius Moradpour, Nazzareno Capitanio, Claudia Piccoli. Targeting mitochondria in the infection strategy of the hepatitis C virus. The International Journal of Biochemistry & Cell Biology 2013; 45(1) doi: 10.1016/j.biocel.2012.06.008
45
Mohammad-Ali Jenabian, Vikram Mehraj, Cecilia T. Costiniuk, Kishanda Vyboh, Ido Kema, Kathleen Rollet, Robert Paulino Ramirez, Marina B. Klein, Jean-Pierre Routy. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016; 71(3) doi: 10.1097/QAI.0000000000000859
46
Sonia Molina, Dorothée Missé, Stéphane Roche, Stéphanie Badiou, Jean‐Paul Cristol, Claude Bonfils, Jean‐François Dierick, Francisco Veas, Thierry Levayer, Dominique Bonnefont‐Rousselot, Patrick Maurel, Joliette Coste, Chantal Fournier‐Wirth. Identification of apolipoprotein C‐III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection. PROTEOMICS – Clinical Applications 2008; 2(5) doi: 10.1002/prca.200800020
47
Aliya Qayyum, Daryl M. Chen, Richard S. Breiman, Antonio C. Westphalen, Benjamin M. Yeh, Kirk D. Jones, Ying Lu, Fergus V. Coakley, Peter W. Callen. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?. Clinical Imaging 2009; 33(2) doi: 10.1016/j.clinimag.2008.06.036
48
Elisabetta Cariani, Erica Villa, Cristina Rota, Rosina Critelli, Tommaso Trenti. Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. Clinical Chemistry and Laboratory Medicine (CCLM) 2011; 49(8) doi: 10.1515/CCLM.2011.618
49
Ilkay S. Idilman, Ilknur Ozdeniz, Musturay Karcaaltincaba. Hepatic Steatosis: Etiology, Patterns, and Quantification. Seminars in Ultrasound, CT and MRI 2016; 37(6) doi: 10.1053/j.sult.2016.08.003
50
Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta. Metabolic Factors and Chronic Hepatitis C: A Complex Interplay. BioMed Research International 2013; 2013 doi: 10.1155/2013/564645
51
John Paul Pezacki, Selena M Sagan, Angela M Tonary, Yanouchka Rouleau, Sylvie Bélanger, Lubica Supekova, Andrew I Su. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chemical Biology 2009; 9(1) doi: 10.1186/1472-6769-9-2
52
Deborah L. Diamond, Jon M. Jacobs, Bryan Paeper, Sean C. Proll, Marina A. Gritsenko, Robert L. Carithers, Anne M. Larson, Matthew M. Yeh, David G. Camp, Richard D. Smith, Michael G. Katze. Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction. Hepatology 2007; 46(3) doi: 10.1002/hep.21751
53
Pamela Valva, Elena De Matteo, María C. Galoppo, María I. Gismondi, María V. Preciado. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis. Journal of Medical Virology 2010; 82(6) doi: 10.1002/jmv.21699
54
Joanna Wróblewska, Marcin Wróblewski, Iga Hołyńska-Iwan, Martyna Modrzejewska, Jarosław Nuszkiewicz, Weronika Wróblewska, Alina Woźniak. The Role of Glutathione in Selected Viral Diseases. Antioxidants 2023; 12(7) doi: 10.3390/antiox12071325
55
Stuart McPherson, Julie R. Jonsson, Helen D. Barrie, Peter O’Rourke, Andrew D. Clouston, Elizabeth E. Powell. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. Journal of Hepatology 2008; 49(6) doi: 10.1016/j.jhep.2008.06.022
56
C. Jackel-Cram, L. Qiao, Z. Xiang, R. Brownlie, Y. Zhou, L. Babiuk, Q. Liu. Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway. Journal of General Virology 2010; 91(6) doi: 10.1099/vir.0.017418-0
57
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017;  doi: 10.1007/978-3-319-26956-6_10
58
Nathalie Majeau, Rémi Fromentin, Christian Savard, Marie Duval, Michel J. Tremblay, Denis Leclerc. Palmitoylation of Hepatitis C Virus Core Protein Is Important for Virion Production. Journal of Biological Chemistry 2009; 284(49) doi: 10.1074/jbc.M109.018549
59
Costin‐Ioan Popescu, Jean Dubuisson. Role of lipid metabolism in hepatitis C virus assembly and entry. Biology of the Cell 2010; 102(1) doi: 10.1042/BC20090125
60
Masayoshi Fukasawa. Cellular Lipid Droplets and Hepatitis C Virus Life Cycle. Biological and Pharmaceutical Bulletin 2010; 33(3) doi: 10.1248/bpb.33.355
61
Ileana Hernández, Mayra Domínguez-Pérez, Leticia Bucio, Verónica Souza, Roxana U. Miranda, Dahn L. Clemens, Luis Enrique Gomez-Quiroz, María Concepción Gutiérrez-Ruiz. Free fatty acids enhance the oxidative damage induced by ethanol metabolism in an in vitro model. Food and Chemical Toxicology 2015; 76 doi: 10.1016/j.fct.2014.12.005
62
Jean-Charles Nault. Pathogenesis of hepatocellular carcinoma according to aetiology. Best Practice & Research Clinical Gastroenterology 2014; 28(5) doi: 10.1016/j.bpg.2014.08.006
63
David Durantel, Fabien Zoulim. Antiviral Research. 2014;  doi: 10.1128/9781555815493.ch14
64
Takashi Himoto, Hirohito Yoneyama, Kazutaka Kurokohchi, Hirohito Mori, Michio Inukai, Hisashi Masugata, Fuminori Goda, Reiji Haba, Seishiro Watanabe, Shoich Senda, Tsutomu Masaki. Clinical Relevance of Antibodies to Cardiolipin in Patients with Chronic Hepatitis C. Journal of Clinical Laboratory Analysis 2012; 26(5) doi: 10.1002/jcla.21529
65
Urpo Nieminen, Perttu E. T. Arkkila, Päivi Kärkkäinen, Martti A. Färkkilä. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C. Liver International 2009; 29(2) doi: 10.1111/j.1478-3231.2008.01779.x
66
Liqing Yu, Yi Li, Alison Grisé, Huan Wang. Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease. Advances in Experimental Medicine and Biology 2020; 1276 doi: 10.1007/978-981-15-6082-8_13
67
Rachel Abraham, Banumathi Ramakrishna, Avinash Balekuduru, Hubert Darius J. Daniel, Priya Abraham, C. Eapen Eapen, George Kurian. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease. Indian Journal of Gastroenterology 2009; 28(2) doi: 10.1007/s12664-009-0018-z
68
Eliana Z. Agudelo, Norah A. Terrault. Optimizing therapy in treatment-naïve genotype 1 patients. Current Hepatitis Reports 2008; 7(2) doi: 10.1007/s11901-008-0010-6
69
Chunhua Li, Hong Cao, Ling Lu, Donald Murphy. Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns.  Journal of General Virology 2012; 93(6) doi: 10.1099/vir.0.038315-0
70
Douglas Chee, Cheng Han Ng, Kai En Chan, Daniel Q. Huang, Margaret Teng, Mark Muthiah. The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases. Medical Clinics of North America 2023; 107(3) doi: 10.1016/j.mcna.2022.12.001
71
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert. Mouse models for the study of HCV infection and virus–host interactions. Journal of Hepatology 2008; 49(1) doi: 10.1016/j.jhep.2008.03.012
72
Ewa Przybytkowski, Maik Behrendt, David Dubois, Dusica Maysinger. Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. The FEBS Journal 2009; 276(21) doi: 10.1111/j.1742-4658.2009.07324.x
73
Mariana V. Machado, Helena Cortez-Pinto. Insulin resistance and steatosis in chronic hepatitis C. Annals of Hepatology 2009; 8 doi: 10.1016/S1665-2681(19)31829-0
74
Maria Guido, Alessandra Mangia, Neil D. Theise. MacSween's Pathology of the Liver. 2024;  doi: 10.1016/B978-0-7020-8228-3.00006-5
75
Ricardo Ulises Macías-Rodríguez, Astrid Ruiz-Margáin, Ignacio García-Juárez, Nayelli C Flores-García, Alberto Adrián Solís-Ortega, Ivonne Hurtado-Díaz-de-León, José A González-Regueiro, Berenice M Román-Calleja, Alejandro Campos-Murguía. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19. World Journal of Gastroenterology 2021; 27(33): 5502-5519 doi: 10.3748/wjg.v27.i33.5502
76
HELGE MYRMEL, ELLING ULVESTAD, BIRGITTA ÅSJØ. The hepatitis C virus enigma. APMIS 2009; 117(5-6) doi: 10.1111/j.1600-0463.2009.02454.x
77
Maria Guido, Alessandra Mangia, Gavino Faa. Chronic viral hepatitis: The histology report. Digestive and Liver Disease 2011; 43 doi: 10.1016/S1590-8658(11)60589-6
78
C. Piccoli, G. Quarato, M. Ripoli, A. D'Aprile, R. Scrima, O. Cela, D. Boffoli, D. Moradpour, N. Capitanio. HCV infection induces mitochondrial bioenergetic unbalance: Causes and effects. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2009; 1787(5) doi: 10.1016/j.bbabio.2008.11.008
79
Aliya Qayyum. MR Spectroscopy of the Liver: Principles and Clinical Applications. RadioGraphics 2009; 29(6) doi: 10.1148/rg.296095520
80
Ted Bader, Javid Fazili, Mohammed Madhoun, Christopher Aston, Diane Hughes, Syed Rizvi, Ken Seres, Muhammad Hasan. Fluvastatin Inhibits Hepatitis C Replication in Humans. The American Journal of Gastroenterology 2008; 103(6) doi: 10.1111/j.1572-0241.2008.01876.x
81
O Adekanle, MM Oje, DA Ndububa. Malignant transformation of cirrhotic liver. Nigerian Journal of Health Sciences 2020; 20(2) doi: 10.4103/njhs.njhs_30_20
82
Timothy L. Tellinghuisen, Matthew J. Evans, Thomas von Hahn, Shihyun You, Charles M. Rice. Studying Hepatitis C Virus: Making the Best of a Bad Virus. Journal of Virology 2007; 81(17) doi: 10.1128/JVI.00753-07
83
Benno Wölk, Heiner Wedemeyer, Kris Kowdley. Hepatitis C virus living off the fat of the land. Hepatology 2008; 47(1) doi: 10.1002/hep.22145
84
Anand Rattansingh, Hosein Amooshahi, Ravi J Menezes, Florence Wong, Sandra Fischer, Richard Kirsch, Mostafa Atri. Utility of shear‐wave elastography to differentiate low from advanced degrees of liver fibrosis in patients with hepatitis C virus infection of native and transplant livers. Journal of Clinical Ultrasound 2018; 46(5) doi: 10.1002/jcu.22583
85
Munechika Enjoji, Motoyuki Kohjima, Makoto Nakamuta. The Liver in Systemic Diseases. 2016;  doi: 10.1007/978-4-431-55790-6_6
86
G. I. Nepomnyashchikh, M. A. Bakarev, D. L. Nepomnyashchikh, A. V. Yudanov, V. I. Kapustina, E. I. Migus’kova, O. A. Postnikova, E. V. Vinogradova, Zh. V. Nokhrina, S. A. Savchenko. Role of Lipid Infiltration of Hepatocytes in the Morphogenesis of Chronic Hepatitis C. Bulletin of Experimental Biology and Medicine 2013; 156(2) doi: 10.1007/s10517-013-2330-y
87
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
88
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1) doi: 10.5812/hepatmon.4295
89
Analysis of the Prevalence of Cardiovascular Risk Factors in Patients with Chronic Hepatitis C. Journal of Cardiovascular Medicine and Cardiology 2024; 11(4) doi: 10.17352/2455-2976.000210
90
Hesham M. Elgouhari, Hari S. Conjeevaram. Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes. Current Hepatitis Reports 2008; 7(3) doi: 10.1007/s11901-008-0026-y
91
Kohichiroh Yasui, Yuichi Harano, Hironori Mitsuyoshi, Kazuhiro Tsuji, Mio Endo, Tomoaki Nakajima, Masahito Minami, Yoshito Itoh, Yoh Zen, Yasuni Nakanuma, Toshikazu Yoshikawa, Takeshi Okanoue. Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus. Journal of Gastroenterology 2010; 45(1) doi: 10.1007/s00535-009-0133-8
92
Amany Talaat, Amr Fatin, Ahmed Elsawy. Hepatic steatosis in HCV infection genotype 4 in Egypt. Egyptian Liver Journal 2012; 2(1) doi: 10.1097/01.ELX.0000403334.90863.91
93
Francesco Paparo, Giovanni Cenderello, Matteo Revelli, Lorenzo Bacigalupo, Mariangela Rutigliani, Daniele Zefiro, Luca Cevasco, Maria Amico, Roberto Bandelloni, Giovanni Cassola, Gian Luca Forni, Gian Andrea Rollandi. Diagnostic Value of MRI Proton Density Fat Fraction for Assessing Liver Steatosis in Chronic Viral C Hepatitis. BioMed Research International 2015; 2015 doi: 10.1155/2015/758164
94
Giovanni Guaraldi, Amedeo Lonardo, Stefano Ballestri, Stefano Zona, Chiara Stentarelli, Gabriella Orlando, Federica Carli, Lucia Carulli, Alberto Roverato, Paola Loria. Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. Archives of Medical Research 2011; 42(8) doi: 10.1016/j.arcmed.2011.12.009
95
Shira Zelber-Sagi, Azmi Shahbari, Fahmi Shibli, Ofir Ben-Assuli, Elchanan Nussinson, Shira Yair-Sabag. Retrospective study of the associations between hepatitis C virus infection and metabolic factors. World Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
96
María Hernández‐Pérez, Daniel Riado, Eva Pena, Carmen Méndez, Fernando Pinedo, Paloma Ramos, Pilar Castillo, Miriam Romero, Conrado Fernández‐Rodríguez, Antonio Olveira. The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis. Alimentary Pharmacology & Therapeutics 2024; 60(5) doi: 10.1111/apt.18134
97
Chao-Min Huang, Kuo-Chin Chang, Chao-Hung Hung, King-Wah Chiu, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Kwong-Ming Kee, Yuan-Hung Kuo, Ming-Chao Tsai, Po-Lin Tseng, Ming-Tsung Lin, Cheng-Kun Wu, Tsung-Hui Hu, Chung-Lung Cho, Yi-Hao Yen, Salvatore Petta. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0182204
98
Manisha Bahl, Aliya Qayyum, Antonio C. Westphalen, Susan M. Noworolski, Philip W. Chu, Linda Ferrell, Phyllis C. Tien, Nathan M. Bass, Raphael B. Merriman. Liver Steatosis: Investigation of Opposed-Phase T1-weighted Liver MR Signal Intensity Loss and Visceral Fat Measurement as Biomarkers. Radiology 2008; 249(1) doi: 10.1148/radiol.2491071375
99
Birke Bartosch, Jean Dubuisson. Recent Advances in Hepatitis C Virus Cell Entry. Viruses 2010; 2(3) doi: 10.3390/v2030692
100
Emilio González Reimers, Javier López Prieto, M. Remedios Alemán Valls, Ana Castellano-Higuera. Esteatosis hepática y grasa corporal en pacientes coinfectados por los virus de la inmunodeficiencia humana y de la hepatitis C. Medicina Clínica 2010; 134(4) doi: 10.1016/j.medcli.2009.04.053
101
Mehlayl Tariq, Abu Bakar Shoukat, Sedrah Akbar, Samaia Hameed, Muniba Zainab Naqvi, Ayesha Azher, Muhammad Saad, Muhammad Rizwan, Muhammad Nadeem, Anum Javed, Asad Ali, Shahid Aziz. Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection. SAGE Open Medicine 2022; 10 doi: 10.1177/20503121221105957
102
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 2009; 51(4) doi: 10.1016/j.jhep.2009.05.008
103
Judith M. Gottwein, Jens Bukh. . Advances in Virus Research 2008; 71 doi: 10.1016/S0065-3527(08)00002-X
104
M. Alaei, F. Negro. Hepatitis C virus and glucose and lipid metabolism. Diabetes & Metabolism 2008; 34(6) doi: 10.1016/S1262-3636(08)74606-8
105
Chul-Yong Park, Hyun-Jeong Jun, Takaji Wakita, Jae Hun Cheong, Soon B. Hwang. Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway. Journal of Biological Chemistry 2009; 284(14) doi: 10.1074/jbc.M808773200
106
Gabrielle Vieyres, Kathrin Welsch, Gisa Gerold, Juliane Gentzsch, Sina Kahl, Florian W. R. Vondran, Lars Kaderali, Thomas Pietschmann, Timothy L. Tellinghuisen. ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production. PLOS Pathogens 2016; 12(4) doi: 10.1371/journal.ppat.1005568
107
Tomoko Hyodo, Norihisa Yada, Osamu Maenishi, Mitsuru Matsuki, Takamichi Murakami. Hepatic steatosis and fibrosis: evaluation with CT imaging. Kanzo 2018; 59(8) doi: 10.2957/kanzo.59.393
108
Nora Anderson, Jürgen Borlak. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacological Reviews 2008; 60(3) doi: 10.1124/pr.108.00001
109
Sadaf Badar, Bushra Khubaib, Muhammad Idrees, Abrar Hussain, Zunaira Awan, Sadia Butt, Samia Afzal, Madeeha Akram, Zareen Fatima, Mahwish Aftab, Sana Saleem, Sara Munir, Bisma Rauff, Mahrukh Naudhani, Liaquat Ali, Muhammaad Ali, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1) doi: 10.5812/kowsar.1735143X.4295
110
John McLauchlan. Lipid droplets and hepatitis C virus infection. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009; 1791(6) doi: 10.1016/j.bbalip.2008.12.012
111
Elisabetta Cariani, Rosina Critelli, Cristina Rota, Monica Luongo, Tommaso Trenti, Erica Villa. Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C. Journal of Virological Methods 2011; 178(1-2) doi: 10.1016/j.jviromet.2011.08.021
112
Thierry Poynard, Nezam H Afdhal. Perspectives on Fibrosis Progression in Hepatitis C: An à la Carte Approach to Risk Factors and Staging of Fibrosis. Antiviral Therapy 2010; 15(3) doi: 10.3851/IMP1535
113
Jiyoung Lee, Jing-hsiung James Ou. Cellular Injury in Liver Diseases. 2017;  doi: 10.1007/978-3-319-53774-0_4
114
Dorota Zarębska-Michaluk. Genotype 3-hepatitis C virus’ last line of defense. World Journal of Gastroenterology 2021; 27(11): 1006-1021 doi: 10.3748/wjg.v27.i11.1006
115
Joana Rita Carvalho, José Velosa, Fátima Serejo. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimens. Scandinavian Journal of Gastroenterology 2018; 53(7) doi: 10.1080/00365521.2018.1473486
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.